245 results
424B3
CYDY
CytoDyn Inc.
16 Apr 24
Prospectus supplement
5:16pm
forward-looking statements. Except as required by law, we do not undertake any responsibility to update these forward-looking statements to address events … or circumstances that occur after the date of this quarterly report. Additionally, we do not undertake any responsibility to update you
424B3
CYDY
CytoDyn Inc.
16 Apr 24
Prospectus supplement
5:15pm
forward-looking statements. Except as required by law, we do not undertake any responsibility to update these forward-looking statements to address events … or circumstances that occur after the date of this quarterly report. Additionally, we do not undertake any responsibility to update you
424B3
CYDY
CytoDyn Inc.
29 Jan 24
Prospectus supplement
5:22pm
direct responsibility for the Company’s business affairs and related needs, and will serve as the Principal Executive Officer of the Company
8-K
EX-99.1
da8g7e8cpxe0xti691v
29 Jan 24
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
8:40am
8-K
EX-10.1
3aaghd uygqn5f
29 Jan 24
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
8:40am
424B3
x76j1hv
19 Jan 24
Prospectus supplement
5:15pm
424B3
3koycbixchy 43puxe9d
22 Nov 23
Prospectus supplement
12:16pm
8-K
EX-99.1
08qm r0xaqabg9a
21 Nov 23
CytoDyn Appoints Jacob Lalezari M.D. as Interim CEO
5:15pm
8-K
EX-10.1
hbxd7k 4o680
21 Nov 23
CytoDyn Appoints Jacob Lalezari M.D. as Interim CEO
5:15pm
424B3
53s7x
24 Oct 23
Prospectus supplement
6:01am
424B3
sf7sw 9gc
10 Oct 23
Prospectus supplement
6:02pm
POS AM
ydfmxxob9
2 Oct 23
Prospectus update (post-effective amendment)
5:15pm